ARCHIVES

Pretreatment with Azacitidine Achieves 28-Month Remission

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

December 5, 2014

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995